R. Caprilli

10.5k total citations
132 papers, 5.4k citations indexed

About

R. Caprilli is a scholar working on Genetics, Epidemiology and Surgery. According to data from OpenAlex, R. Caprilli has authored 132 papers receiving a total of 5.4k indexed citations (citations by other indexed papers that have themselves been cited), including 84 papers in Genetics, 66 papers in Epidemiology and 49 papers in Surgery. Recurrent topics in R. Caprilli's work include Inflammatory Bowel Disease (80 papers), Microscopic Colitis (56 papers) and Helicobacter pylori-related gastroenterology studies (21 papers). R. Caprilli is often cited by papers focused on Inflammatory Bowel Disease (80 papers), Microscopic Colitis (56 papers) and Helicobacter pylori-related gastroenterology studies (21 papers). R. Caprilli collaborates with scholars based in Italy, United States and United Kingdom. R. Caprilli's co-authors include Angelo Viscido, Giovanni Latella, Piero Vernia, Giuseppe Frieri, Adriana Marcheggiano, Giovanni Corrao, Francesca Maccioni, Claudio Papi, Antonella Vetuschi and Roberta Sferra and has published in prestigious journals such as The Lancet, Annals of Internal Medicine and Gastroenterology.

In The Last Decade

R. Caprilli

131 papers receiving 5.2k citations

Peers

Countries citing papers authored by R. Caprilli

Since Specialization

Citations

This map shows the geographic impact of R. Caprilli's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R. Caprilli with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R. Caprilli more than expected).

Fields of papers citing papers by R. Caprilli

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by R. Caprilli. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R. Caprilli. The network helps show where R. Caprilli may publish in the future.

Co-authorship network of co-authors of R. Caprilli

This figure shows the co-authorship network connecting the top 25 collaborators of R. Caprilli. A scholar is included among the top collaborators of R. Caprilli based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with R. Caprilli. R. Caprilli is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Treatment of inflammatory bowel diseases: To heal the wound or to heal the sick? 2012 ·Journal of Crohn s and Colitis ·R. Caprilli, Giovanni Latella, Giuseppe Frieri	11
2	The long journey of salicylates in ulcerative colitis: The past and the future 2009 ·Journal of Crohn s and Colitis ·R. Caprilli, Monica Cesarini, Erika Angelucci, Giuseppe Frieri	31
3	Mesalazine vanishing time from rectal mucosa following its topical administration 2009 ·Journal of Crohn s and Colitis ·M.T. Pimpo, (unknown), Giancarlo Palumbo, Angelo Viscido, Patrick S. Gentile, R. Caprilli, Giuseppe Frieri	19
4	Smad3 loss confers resistance to the development of trinitrobenzene sulfonic acid–induced colorectal fibrosis 2009 ·European Journal of Clinical Investigation ·Giovanni Latella, Antonella Vetuschi, Roberta Sferra, G. Zanninelli, Angela D’Angelo, (unknown), R. Caprilli, Kathleen C. Flanders, Eugenio Gaudio	50
5	Why does Crohn's disease usually occur in terminal ileum? 2008 ·Journal of Crohn s and Colitis ·R. Caprilli	25
6	Late-breaking news from the “4th International Meeting on Inflammatory Bowel Diseases” Capri, 2006 2007 ·Inflammatory Bowel Diseases ·Giovanni Latella, Claudio Fiocchi, R. Caprilli	1
7	Mucosal features and granulocyte–monocyte-apheresis in steroid-dependent/refractory ulcerative colitis 2006 ·Digestive and Liver Disease ·(unknown), Annalisa Aratari, Angelo Viscido, Adriana Marcheggiano, Claudio Papi, Lucio Capurso, R. Caprilli	19
8	Inflammatory bowel diseases: clinical update of practical guidelines 2005 ·Nuclear Medicine Communications ·Angelo Viscido, Annalisa Aratari, Francesca Maccioni, Alberto Signore, R. Caprilli	16
9	Two synchronous adenocarcinomas of the small bowel in a patient with undiagnosed Crohn's disease of the terminal ileum 2005 ·International Journal of Colorectal Disease ·Paolo Sammartino, Simone Sibio, Angelo Di Giorgio, Roberto Caronna, Angelo Viscido, Maddalena Zippi, Daniele Biacchi, Fabio Accarpio, P Mingazzini, R. Caprilli	4
10	Optimisation of isolation of richly pure and homogeneous primary human colonic smooth muscle cells 2004 ·Digestive and Liver Disease ·Ivan Tattoli, Vito D. Corleto, (unknown), Nicoletta Campanini, Guido Rindi, R. Caprilli, G. Delle Fave, Carola Severi	19
11	Two mesalazine regimens in the prevention of the post‐operative recurrence of Crohn's disease: a pragmatic, double‐blind, randomized controlled trial 2003 ·Alimentary Pharmacology & Therapeutics ·R. Caprilli, Mario Cottone, Francesco Tonelli, Giacomo Carlo Sturniolo, Fabiana Castiglione, Vito Annese, Claudio Papi, Angelo Viscido, Calogero Cammà, Giovanni Corrao, Giovanni Latella	68
12	Topical butyrate improves efficacy of 5‐ASA in refractory distal ulcerative colitis: results of a multicentre trial 2003 ·European Journal of Clinical Investigation ·Piero Vernia, Vito Annese, G. Bresci, (unknown), R. D’Incà, S Giaccari, Matilde Ingrosso, C. Mansi, Gabriele Riegler, D. Valpiani, R. Caprilli, (unknown)	167
13	MRI evaluation of Crohn's disease of the small and large bowel with the use of negative superparamagnetic oral contrast agents 2002 ·Abdominal Imaging ·Francesca Maccioni, Angelo Viscido, Mario Marini, R. Caprilli	46
14	Evolving concepts on inflammatory bowel disease. Are we happy with the present nosology? 1999 ·PubMed ·R. Caprilli, Angelo Viscido	7
15	Topical treatment of refractory distal ulcerative colitis with 5-ASA and sodium butyrate 1995 ·Digestive Diseases and Sciences ·Piero Vernia, (unknown), R. Caprilli, A Torsoli	57
16	Gastric and Duodenal Juxtamucosal pH and <i>Helicobacter pylor</i><i>i</i> 1995 ·Digestion ·Giuseppe Frieri, Giovanni De Petris, Annalisa Aggio, Danielle M. Santarelli, (unknown), (unknown), R. Caprilli	8
17	Short‐chain fatty acid topical treatment in distal ulcerative colitis 1995 ·Alimentary Pharmacology & Therapeutics ·Piero Vernia, Adriana Marcheggiano, R. Caprilli, Giuseppe Frieri, Giovanni Corrao, D. Valpiani, Maria Carla Di Paolo, P. Paoluzi, A Torsoli	188
18	Oral mesalazine (5‐aminosalicylic acid; Asacol) for the prevention of post‐operative recurrence of Crohn's disease 1994 ·Alimentary Pharmacology & Therapeutics ·R. Caprilli, (unknown), Lucio Capurso, Giulia Corrao, (unknown), (unknown), (unknown), Iacopo Paladini, Francesco Pallone, V. Ponti, G.P. Rigo, F. P. Rossini, G.C. Sturniolo, Francesco Tonelli, (unknown), (unknown)	156
19	Topical treatment with 5-ASA supositories in distal ulcerative colitis. A randomized double blind placebo controlled study with Asacol suppositories. An Italian co-operative study group 1989 ·Massimo Campieri, Giuseppe Brunetti, M. Miglioli, Barbara Leggett, Antonio Russo, Giuseppe Aprile, G. Bianchi Porro, Sandro Ardizzone, R. de Franchis, Giuseppe Grandinetti, Maurizio Vecchi, T Ranzi, Mauro Campanini, (unknown), Gabriele Riegler, G. Mazzacca, A. D’Arienzo, R. Caprilli, Giuseppe Frieri	1
20	Blood pH: a test for assessment of severity in proctocolitis. 1976 ·Gut ·R. Caprilli, Piero Vernia, (unknown), A Torsoli	21

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact